PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Prescriber10.1002/psb.99820122323-2442-46Boceprevir and telaprevir: new treatments for chronic hepatitis CSteve Chaplin, Geoffrey Dusheikohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsb.998, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsb.998, http://onlinelibrary.wiley.com/wol1/doi/10.1002/psb.998/fullpdf
Clinics in Liver Disease10.1016/j.cld.2021.06.0112021254831-839New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus InfectionLisa Sandmann, Heiner Wedemeyerhttps://api.elsevier.com/content/article/PII:S1089326121000611?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1089326121000611?httpAccept=text/plain
The Korean Journal of Hepatology10.3350/kjhep.2010.16.3.2632010163263New treatments for chronic hepatitis CJae Young Jang, Raymond T. Chunghttp://synapse.koreamed.org/pdf/10.3350/kjhep.2010.16.3.263, http://synapse.koreamed.org/DOIx.php?id=10.3350/kjhep.2010.16.3.263, http://www.e-cmh.org/upload/pdf/kjhep-16-263.pdf
Baillière's Clinical Gastroenterology10.1016/s0950-3528(96)90009-31996102299-333New treatments for chronic viral hepatitis B and CGeoffrey M. Dusheikohttps://api.elsevier.com/content/article/PII:S0950352896900093?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0950352896900093?httpAccept=text/plain
Médecine et Maladies Infectieuses10.1016/j.medmal.2011.04.00320114111579-587New treatments for chronic hepatitis C virus infectionM. Corouge, S. Polhttps://api.elsevier.com/content/article/PII:S0399077X11001582?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0399077X11001582?httpAccept=text/plain
Journal of Viral Hepatitis10.1111/jvh.51_1242520152246-47P054: The response rates of current chronic viral Hepatitis B treatmentshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.51_12425, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjvh.51_12425, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.51_12425/fullpdf
Therapeutics and Clinical Risk Management10.2147/tcrm.s501702014387New treatments for genotype 1 chronic hepatitis C – focus on simeprevirTatsuo Kanda, Shingo Nakamoto, Shuang Wu, Osamu Yokosukahttps://www.dovepress.com/getfile.php?fileID=20174
Digestive Diseases and Sciences10.1007/s10620-015-3818-2201560113153-3154New, Expensive Treatments for Chronic Hepatitis C: Insuring Good Outcomes?Jeremy D. Goldhaber-Fieberthttp://link.springer.com/content/pdf/10.1007/s10620-015-3818-2.pdf, http://link.springer.com/article/10.1007/s10620-015-3818-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10620-015-3818-2
Journal of Gastroenterology and Hepatology10.1046/j.1440-1746.17.s3.41.x200217S434-S436Progression from chronic hepatitis to hepatocellular carcinoma: Natural course and treatmentsMASAO OMATA, HARUHIKO YOSHIDA, YASUSHI SHIRATORI, SHUICHIRO SHIINAhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1746.17.s3.41.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1746.17.s3.41.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1746.17.s3.41.x/fullpdf
Value in Health10.1016/j.jval.2017.08.29552017209A935Access to New Treatments For Chronic Hepatitis C in Four Latin American CountriesNT Giao Antunes, A Ribeiro, M Ascano, R Moorehttps://api.elsevier.com/content/article/PII:S1098301517332898?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301517332898?httpAccept=text/plain